Broers MC,Bunschoten C,Nieboer D,Lingsma HF,Jacobs BC .2019 .Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology, 10(3-4) : 161-172.
Iijima M,Koike H,Hattori N,Tamakoshi A,Katsuno M,Tanaka F .2007 .Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry, 10(9) : 1040-1043.
Oaklander AL,Lunn MP,Hughes RA,Van Schaik IN,Frost C,Chalk CH .2017 .1(1):CD010369. Cochrane Database Syst Rev, 10 : .
Dyck PJ,O'Brien P,Swanson C,Low P,Daube J .1985 .Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology, 10(8) : 1173-1176.
.2009 .Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicenter study. Lancet Neurol, 4422(08) : 70299-0.
Khalid E,Khan H,Nasir A,Abdullah M. .2020 .Referral patterns and diagnoses at a single Neurophysiology Center in Quetta, Pakistan: An audit of 1600 Cases. , 15(3) : 17-21.
Jan Z,Hassan MH,Salman F,Shahzad W,Zarminahil R,Badshah M. .2019 .An analysis of pattern and burden of patients Referred for nerve conduction study in a Tertiary care hospital in Pakistan. Pak J Neurol Sci, 14(3) : 31-36.
Gaebel K,Blackhouse G,Campbell K,Robertson D,Xie F,Assasi N .2010 .Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Open Med, 4(3) : e154.
Breiner A,Barnett C,Bril V .2014 .INCAT disability score: a critical analysis of its measurement properties. Muscle Nerve, 10(2) : 164-169.
Van Schaik IN,Eftimov F,Van Doorn PA,Brusse E,Van den Berg LH,Van der Pol WL .2010 .Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double blind, randomised, controlled trial. Lancet Neurol, 4422(10) : 70021-1.
Cornblath DR .1991 .Report from an Ad Hoc Subcommittiee of the American academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology, 42 : 617-618.
Guptill JT,Runken MC,Eaddy M,Lunacsek O,Fuldeore RM .2019 .Treatment patterns and costs of chronic inflammatory demyelinating polyneuropathy: a claims database analysis. Am Health Drug Benefits, 12(3) : 127-135.
.2014 .. British National Formulary. 8th Edition, : .
Ryan MM,Grattan-Smith PJ,Procopis PG,Morgan G,Ouvrier RA .2000 .Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and longterm outcome. Neuromuscul Disord, 8966(00) : 00119-x.
Dalakas MC,Engel WK .1981 .Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol, 10 : 134-145.
Monaco S,Turri E,Zanusso G,Maistrello B .2004 .Treatment of inflammatory and paraproteinemic neuropathies. Curr Drug Targets Immune Endocr Metabol Disord, 10(2) : 141-148.
Cocito D,Grimaldi S,Paolasso I,Falcone Y,Antonini G,Benedetti L .2011 .Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis. Eur J Neurol, 03495(12) : 1331-1421.
Odaka M,Tatsumoto M,Susuki K,Hirata K Yuki N. K .2003 .Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin. J Neurol Neurosurg Psychiatry, 10(8) : 1115-1120.
Hodgkinson SJ,Pollard JD,McLeod JG .1990 .Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry, 10(4) : 327-330.
Barnett MH,Pollard JD,Davies L,McLeod JG .1998 .:aid-mus3>3.0. Muscle Nerve, 10(199804) : 2-8.
Rison RA,Beydoun SR .2016 .Paraproteinemic neuropathy: a practical review. BMC Neurol, 10 : 13.
Viala K,Béhin A,Maisonobe T,Leger JM,Stojkovic T,Davi F .2007 .Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis?. J Neurol Neurosurg Psychiatry, 10(7) : 778-782.